Telemedicine Prescribing Law for Controlled Substances
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008
Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- DEA-administered; amends the Controlled Substances Act
Reference only. Not medical advice.
What can go wrong
A telehealth model that prescribes testosterone without satisfying Ryan Haight (an in-person exam, a valid exception, or an active flexibility) risks DEA enforcement against the prescriber and pharmacy. For patients, an offer of online testosterone with no in-person evaluation and no clear legal basis is a red flag about the operation's compliance.
This is something to take to a clinician. The Atlas can tell you what is known about telemedicine prescribing law for controlled substances in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 amended the Controlled Substances Act to require, for any controlled substance dispensed via the internet, a 'valid prescription' based on at least one in-person medical evaluation, unless a narrow telemedicine exception applies. Because testosterone is Schedule III, Ryan Haight governs online TRT prescribing. Its seven statutory telemedicine exceptions mostly require the patient to be in a clinic or with another practitioner, not the at-home model most direct-to-consumer telehealth uses.
The 2008 law that says you generally cannot get controlled meds online without ever seeing a doctor in person.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Ryan Haight makes it unlawful to deliver, distribute, or dispense a controlled substance by means of the internet without a valid prescription, defined to require at least one in-person medical evaluation of the patient (or coverage under a recognized telemedicine exception). The exceptions largely contemplate the patient being physically located in a registered hospital/clinic or in the presence of a DEA-registered practitioner, conditions that do not fit the patient-at-home, provider-at-home model of modern DTC telehealth. After an in-person exam exists, a practitioner may use telehealth for follow-up prescribing.
Why TRT telehealth is legally trickier than ED telehealth
Sildenafil and tadalafil are not controlled substances, so ED telehealth never touches Ryan Haight, a major reason online ED scaled so easily. Testosterone is Schedule III, so online TRT runs straight into the in-person-evaluation requirement. During COVID-19 the DEA waived the in-person rule via temporary flexibilities, and these have been extended repeatedly (the most recent extension running into 2026) while DEA works toward a permanent special-registration framework. The marketplace's frictionless online-TRT promise rests on these still-temporary flexibilities, not on settled law.
What people get wrong
Often saidOnline testosterone is just like online Viagra
ActuallyViagra is not controlled; testosterone is Schedule III, so Ryan Haight's in-person-evaluation rule applies to online TRT.
Often saidThe in-person rule is permanently waived
ActuallyThe waiver is a series of temporary COVID-era extensions, not settled permanent law; a special-registration framework is still pending.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Statute
- Ryan Haight Act of 2008 (amends the Controlled Substances Act)
- Core rule
- Valid online prescription requires >=1 in-person evaluation
- Exceptions
- Seven narrow telemedicine categories
- Named after
- Ryan Haight, who died at 18 from drugs bought online without a real exam
- Post-2020
- COVID-era flexibilities repeatedly extended; permanent rule still unsettled
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Telemedicine Prescribing Law for Controlled Substances. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Ryan Haight Online Pharmacy Consumer Protection Act2008
Required in-person evaluation for online controlled-substance prescriptions
DEA COVID-19 telemedicine flexibilities2020-2026
Temporarily waived the in-person rule; repeatedly extended pending a permanent rule